Related Experiment Video
Updated: Aug 5, 2026
Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Effects of intranasal dexmedetomidine on postoperative sleep quality: a systematic review and meta-analysis of
Jiacheng Zhao1, Chao Zhang1, Hui Li1
1Department of Anesthesiology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
Background:
Postoperative sleep disturbance is common in surgical patients and may slow recovery. Dexmedetomidine has a sleep like sedative effect, and intranasal administration provides a convenient and non-invasive route. The aim of our study was to evaluate the effect of intranasal dexmedetomidine on postoperative sleep quality in adult surgical patients.
Methods:
We performed a systematic review and meta-analysis of randomized controlled trials. PubMed, the Cochrane Library and Embase were searched to May 20, 2026. Intranasal dexmedetomidine was compared with placebo or other controls. Subjective and objective sleep outcomes, sleep disturbance and adverse events were analysed using standard meta-analytic methods. Subgroup analyses were further performed according to the route, timing, and duration of administration, as well as patient characteristics, surgical type, anesthesia type, and evaluation scales.
Results:
15 trials were included. For subjective scores where a lower value means better sleep, intranasal dexmedetomidine improved postoperative sleep compared with controls (SMD = -1.29, 95% CI [-1.80, -0.77], I 2 = 90%, p < 0.00001). Subgroup analyses suggested that the timing of administration, sex distribution, and surgical type might be important sources of heterogeneity. For scores where a higher value means better sleep, postoperative scores were also higher in the dexmedetomidine group (SMD = 1.75, 95% CI [0.94, 2.57], I 2 = 94%, p < 0.0001). Sleep efficiency (SMD = 1.71, 95% CI [0.94, 2.48], I 2 = 93%, p < 0.0001) and total sleep time (SMD = 1.76, 95% CI [0.67, 2.84], I 2 = 91%, p = 0.002) increased, sleep latency (SMD = -1.07, 95% CI [-1.66, -0.49], I 2 = 86%, p = 0.0003) reduced, while REM sleep, N1 sleep, and N3 sleep did not change. The risk of sleep disturbance decreased (RR = 0.53, 95% CI [0.39, 0.73], I 2 = 74%, p < 0.0001). Adverse events such as delirium, nausea and vomiting, and anxiety were less common in the dexmedetomidine group.
Conclusion:
Intranasal dexmedetomidine may improve short-term postoperative sleep, but evidence is limited and more high-quality trials are needed.
Systematic Review Registration:
PROSPERO 2025 CRD420251186146, Available from https://www.crd.york.ac.uk/PROSPERO/view/CRD420251186146.
Related Concept Videos
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:24Parenteral Anesthetics: Overview
01:22Stages of General Anesthesia
01:23Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:20Inhalational Anesthetics: Overview
01:24General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...